Joan Borras
Overview
Explore the profile of Joan Borras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-Castillejo S, Roig B, Mele M, Serrano S, Salvat M, Querol M, et al.
J Med Genet
. 2023 Aug;
61(1):69-77.
PMID: 37591735
Background: Multigene panel testing by next-generation sequencing (MGP-NGS) enables the detection of germline pathogenic or likely pathogenic variants (PVs/LPVs) in genes beyond those associated with a certain cancer phenotype. Opportunistic...
2.
Guma J, Pena K, Riu F, Guilarte C, Hernandez A, Lucia C, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497340
Liquid biopsy has improved significantly over the last decade and is attracting attention as a tool that can complement tissue biopsy to evaluate the genetic landscape of solid tumors. In...
3.
Rodriguez-Balada M, Roig B, Mele M, Albacar C, Serrano S, Salvat M, et al.
Clin Biochem
. 2019 Dec;
76:17-23.
PMID: 31786208
Background: Approximately 5-10% of breast carcinomas have been related to hereditary conditions and are attributable to pathogenic variants in the BRCA1 and BRCA2 genes, which is referred to as hereditary...
4.
Roig B, Rodriguez-Balada M, Samino S, Lam E, Guaita-Esteruelas S, Gomes A, et al.
Sci Rep
. 2017 Dec;
7(1):17831.
PMID: 29259228
Hereditary breast and ovarian cancer syndrome (HBOC) is partly due to the presence of mutations in the BRCA genes. Triple-negative (TN) breast cancer (BC) shares histological characteristics with germline BRCA1...
5.
Guaita-Esteruelas S, Saavedra-Garcia P, Bosquet A, Borras J, Girona J, Amiliano K, et al.
Oncologist
. 2017 Jul;
22(11):1309-1315.
PMID: 28701570
Background: Adipose tissue is an endocrine organ that could play a role in tumor progression via its secreted adipokines. The role of adipose-derived fatty acid-binding protein (FABP) 4 and FABP5...
6.
Galceran J, Uhry Z, Marcos-Gragera R, Borras J
Eur J Cancer Prev
. 2016 Dec;
:S77-S84.
PMID: 28005609
In Europe as a whole, survival from skin malignant melanoma (SMM) has increased constantly since the 1980s. The aim of the SUDCAN collaborative study was to compare the trends in...
7.
Rodriguez-Balada M, Roig B, Martorell L, Mele M, Salvat M, Vilella E, et al.
Cancer Genet
. 2016 Nov;
209(11):487-492.
PMID: 27886673
Ascertaining the clinical consequences of BRCA1 and BRCA2 variants of uncertain significance (VUS) is currently indispensable for providing effective genetic counseling and preventive actions for families with hereditary breast and...
8.
Guaita-Esteruelas S, Bosquet A, Saavedra P, Guma J, Girona J, Lam E, et al.
Mol Carcinog
. 2016 Apr;
56(1):208-217.
PMID: 27061264
Adipose tissue plays an important role in tumor progression, because it provides nutrients and adipokines to proliferating cells. Fatty acid binding protein 4 (FABP4) is a key adipokine for fatty...
9.
Rodriguez M, Torres A, Borras J, Salvat M, Guma J
Clin Genet
. 2010 Nov;
78(4):405-7.
PMID: 21050186
No abstract available.
10.
Pollan M, Pastor-Barriuso R, Ardanaz E, Arguelles M, Martos C, Galceran J, et al.
J Natl Cancer Inst
. 2009 Oct;
101(22):1584-91.
PMID: 19861303
Background: Since the 1980s, Spain experienced two decades of sharply increasing breast cancer incidence. Declines in breast cancer incidence have recently been reported in many developed countries. We examined whether...